Teladoc Health (NYSE:TDOC) had its target price hoisted by stock analysts at Piper Jaffray Companies to $84.00 in a research note issued to investors on Friday, September 21st, The Fly reports. The brokerage presently has an “overweight” rating on the health services provider’s stock. Piper Jaffray Companies’ price objective would indicate a potential upside of 27.39% from the stock’s previous close.

A number of other research analysts have also recently commented on TDOC. Craig Hallum upgraded Teladoc Health from a “hold” rating to a “buy” rating in a research note on Tuesday, June 5th. JPMorgan Chase & Co. raised their target price on Teladoc Health to $58.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 5th. Canaccord Genuity raised their target price on Teladoc Health from $47.00 to $63.00 and gave the stock a “buy” rating in a research report on Tuesday, June 5th. SunTrust Banks raised their target price on Teladoc Health from $48.00 to $63.00 and gave the stock a “buy” rating in a research report on Tuesday, June 5th. Finally, Cantor Fitzgerald raised their target price on Teladoc Health from $35.00 to $50.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 5th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. Teladoc Health currently has an average rating of “Buy” and an average price target of $79.79.

Shares of TDOC stock traded up $3.51 during trading hours on Friday, reaching $65.94. The company’s stock had a trading volume of 2,619,045 shares, compared to its average volume of 1,270,685. Teladoc Health has a fifty-two week low of $27.30 and a fifty-two week high of $89.05. The company has a market cap of $6.01 billion, a PE ratio of -39.96 and a beta of 0.57. The company has a debt-to-equity ratio of 0.58, a quick ratio of 3.14 and a current ratio of 3.14.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, August 1st. The health services provider reported ($0.37) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.38) by $0.01. Teladoc Health had a negative return on equity of 19.10% and a negative net margin of 37.78%. The company had revenue of $94.60 million during the quarter, compared to analysts’ expectations of $91.56 million. During the same period in the prior year, the company earned ($0.28) EPS. Teladoc Health’s revenue was up 112.1% compared to the same quarter last year. On average, equities analysts predict that Teladoc Health will post -1.51 EPS for the current fiscal year.

In other Teladoc Health news, insider Lewis Levy sold 22,768 shares of Teladoc Health stock in a transaction dated Monday, July 16th. The stock was sold at an average price of $65.77, for a total transaction of $1,497,451.36. Following the completion of the transaction, the insider now owns 7,353 shares in the company, valued at approximately $483,606.81. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Peter A. Mcclennen sold 91,072 shares of Teladoc Health stock in a transaction dated Monday, July 16th. The shares were sold at an average price of $65.84, for a total value of $5,996,180.48. Following the transaction, the president now owns 61,660 shares of the company’s stock, valued at approximately $4,059,694.40. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 269,261 shares of company stock valued at $19,013,966. 3.95% of the stock is currently owned by company insiders.

A number of hedge funds have recently added to or reduced their stakes in the business. CWM LLC lifted its position in shares of Teladoc Health by 2.1% during the 2nd quarter. CWM LLC now owns 53,632 shares of the health services provider’s stock worth $3,113,000 after buying an additional 1,078 shares in the last quarter. Swiss National Bank lifted its position in shares of Teladoc Health by 1.7% during the 1st quarter. Swiss National Bank now owns 94,400 shares of the health services provider’s stock worth $3,804,000 after buying an additional 1,600 shares in the last quarter. Amalgamated Bank lifted its position in shares of Teladoc Health by 22.3% during the 2nd quarter. Amalgamated Bank now owns 9,472 shares of the health services provider’s stock worth $550,000 after buying an additional 1,724 shares in the last quarter. LPL Financial LLC lifted its position in shares of Teladoc Health by 18.6% during the 1st quarter. LPL Financial LLC now owns 11,431 shares of the health services provider’s stock worth $461,000 after buying an additional 1,791 shares in the last quarter. Finally, The Manufacturers Life Insurance Company lifted its position in shares of Teladoc Health by 4.8% during the 1st quarter. The Manufacturers Life Insurance Company now owns 42,984 shares of the health services provider’s stock worth $1,732,000 after buying an additional 1,984 shares in the last quarter.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Article: Bond

The Fly

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.